This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: The Kitasato Institute. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Yumiko Ogasawara: Innovator in Genetic Engineering
Introduction
Yumiko Ogasawara is a prominent inventor based in Kanagawa, Japan. She has made significant contributions to the field of genetic engineering, particularly in the biosynthesis of nemadectin. Her innovative work has led to advancements in the production of biologically active compounds.
Latest Patents
Yumiko Ogasawara holds 1 patent related to her research. The patent involves a recombination of gene groups for the biosynthesis of C-13 hydroxylnemadectin. This invention allows for the attachment of sugar groups to the compound, enhancing its biological activity. The production strain developed through her research utilizes molecular genetic technology to effectively produce C-13 hydroxylnemadectin and C-13 glycosylnemadectin.
Career Highlights
Ogasawara is affiliated with The Kitasato Institute, where she conducts her research. Her work has been instrumental in advancing the understanding of glycosidation processes in avermectin biosynthesis. This has opened new avenues for the development of effective biological agents.
Collaborations
Yumiko has collaborated with notable scientists in her field, including Satoshi Omura and Haruo Ikeda. These partnerships have enriched her research and contributed to the success of her innovative projects.
Conclusion
Yumiko Ogasawara is a trailblazer in genetic engineering, with her patent work paving the way for advancements in the production of biologically active compounds. Her contributions continue to impact the field significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile